Hydrophobically modified polyethylenimine-based ternary complexes for targeting brain tumor: stability, in vitro and in vivo studies

References

• Bahadur K, Landry CB, Aliabadi H, Lavasanifar M, Uludag AH. 2011. Lipid substitution on low molecular weight (0.6–2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression. Acta Biomater. 7:2209–2217.
   PubMed Web of Science ®Google Scholar
• Calzolari A, Luigi ML, Robert P. 2010. Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Onclol. 3:123–134.
   PubMed Web of Science ®Google Scholar
• Caysa H, Hoffmann S, Luetzkendorf J, Mueller LP, Unverzagt S, Mäder K, Mueller T. 2012. Monitoring of xenograft tumor growth and response to chemotherapy by non-invasive in vivo multispectral fluorescence imaging. PLoS One. 7:e47927.
   PubMed Web of Science ®Google Scholar
• CharlieMing Y, Hasan HU. 2012. Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression. J Drug Target. 20:301–328.
   PubMed Web of Science ®Google Scholar
• Chen H, Nan W, Wei X, Wang Y, Lv F, Tang H, et al. 2016. Toxicity, pharmacokinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy. Artif Cells Nanomed Biotechnol. [Epub ahead of print].
   Web of Science ®Google Scholar
• Chiu SJ, Liu S, Perrotti D. 2006. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Rel. 112:199–207.
   PubMed Web of Science ®Google Scholar
• Clements BA, Hsu CY, Kucharski C, Lin X, Rose L, Uludağ H. 2009. Nonviral delivery of basic fibroblast growth factor gene to bone marrow stromal cells. Clin Orthop Relat Res. 467:3129–3137.
   PubMed Web of Science ®Google Scholar
• Dube B, Rose L, Sawant K, Uludag H. 2013. Cholic acid modified 2 kDa polyethylenimine as efficient transfection agent. Biotechnol Prog. 29:1337–1341.
   PubMed Web of Science ®Google Scholar
• Finkel E. 1999. Does cancer therapy trigger cell suicide. Science. 286:2256–2258.
   PubMed Web of Science ®Google Scholar
• Fragkos M, Beard P. 2011. Mitotic catastrophe occurs in the absence of apoptosis in p53-null cells with a defective G1 checkpoint. PLoS One. 6:e22946.
   PubMed Web of Science ®Google Scholar
• Geldenhuys W, Mbimba T, Bui T, Harrison K, Sutariya V. 2011. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. J Drug Target. 19:837–845.
   PubMed Web of Science ®Google Scholar
• Goula D, Benoist C, Mantero S, Merlo G, Levi G, Demeneix BA. 1998. polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 5:1291–1295.
   PubMed Web of Science ®Google Scholar
• Gratton SA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME. 2008. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA. 105:11613–11618.
   PubMed Web of Science ®Google Scholar
• Grzelczak M, Vermant J, Furst EM, Liz-Marzan LM. 2010. Directed self-assembly of nanoparticles. ACS Nano. 4:3591–3605.
   PubMed Web of Science ®Google Scholar
• HosseiniHaji-Fatahaliha M, Jadidi-Niaragh M, Majidi F, Yousefi JM. 2016. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy. Artif Cells Nanomed Biotechnol. 44:1051–1061.
   PubMed Web of Science ®Google Scholar
• Ikonen M, Murtomäki L, Kontturi K. 2008. Controlled complexation of plasmid DNA with cationic polymers: effect of surfactant on the complexation and stability of the complexes. Colloids Surf B Biointerfaces. 66:77–83.
   PubMed Web of Science ®Google Scholar
• Jing F, Li D, Xu W, Liu Y, Wang K, Sui Z. 2014. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery. Pharm Biol. 52:570–574.
   PubMed Web of Science ®Google Scholar
• Joshee N, Bastola DR, Cheng PW. 2002. Transferrin-facilitated lipofection gene delivery strategy: characterization of the transfection complexes and intracellular trafficking. Gene Ther. 13:1991–2004.
   Web of Science ®Google Scholar
• Khalvati B, Sheikhsaran F, Sharifzadeh S, Kalantari T, Behbahani AB, Jamshidzadeh A, Dehshahri A. 2016. Delivery of plasmid encoding interleukin-12 gene into hepatocytes by conjugated polyethylenimine-based nanoparticles. Artif Cells Nanomed Biotechnol. 1–9. DOI: 10.1080/21691401.2016.1202256
   PubMed Web of Science ®Google Scholar
• Kircheis R, Schüller S, Brunner S, Ogris M, Heider KH, Zauner W, Wagner E. 1999. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med. 1:111–120.
   PubMed Web of Science ®Google Scholar
• Klausner RD, Harford J, Van RJ. 1984. Rapid internalization of the transferrin receptor in K562 cells is triggered by ligand binding or treatment with a Phorbol ester. Proc Natl Acad Sci USA. 81:3005–3009.
   PubMed Web of Science ®Google Scholar
• Kopatz I, Remy JS, Behr JP. 2004. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med. 6:769–776.
   PubMed Web of Science ®Google Scholar
• Kutlu C, Çakmak AS, Gümüşderelioğlu M. 2014. Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study. J Microencapsul. 31:700–707.
   PubMed Web of Science ®Google Scholar
• Lemkine GF, Demeneix BA. 2001. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther. 3:178–182.
   PubMed Web of Science ®Google Scholar
• Levine AJ. 1997. P53, the cellular gatekeeper for growth and division. Cell. 88:323–331.
   PubMed Web of Science ®Google Scholar
• Lian J, Xin Z, Ming L, Yan D, Nongyue H. 2014. Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics. 4:240–255.
   PubMed Web of Science ®Google Scholar
• LiuCong J, Thomas LE, Ahlborn TE, Michael J, Lou SM, Linda MB. 1999. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M1. Cell Growth Differ. 10:677–683.
   PubMedGoogle Scholar
• Meier P, Vousden KH. 2007. Lucifer's Labyrinth – ten years of path finding in cell death. Mol Cell. 28:746–754.
   PubMed Web of Science ®Google Scholar
• Mulherkar R, Goud AP, Wagle AS, Naresh KN, Mahimkar MB, Thomas SM. 1997. Establishment of a human squamous cell carcinoma cell line of the upper aero-digestive tract. Cancer Lett. 118:115–121.
   PubMed Web of Science ®Google Scholar
• Mulherkar R. 2010. Gene and cell therapy in India. Curr Sci. 99:1542–1548.
   Web of Science ®Google Scholar
• Murk JLAN, Humbel BM, Ziese U, Griffith JM, Posthuma G, Slot JW, et al. 2003. Endosomal compartmentalization in three dimensions: implications for membrane fusion. PNAS. 100:13332–13337.
   PubMed Web of Science ®Google Scholar
• Nakase M, Madoka I, Kenya O, Takahiko K, Shinnosuke N, Toshiro T. 2005. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol Cancer Ther. 4:625–631.
   PubMed Web of Science ®Google Scholar
• Neu M, Sitterberg J, Bakowsky U, Kissel T. 2006. Stabilized nanocarriers for plasmids based upon cross-linked poly(ethyleneimine). Biomacromolecules. 7:3428–3438.
   PubMed Web of Science ®Google Scholar
• Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E. 1998. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Therapy. 5:1425–1433.
   PubMed Web of Science ®Google Scholar
• Pandey AP, Girase NM, Patil MD, Patil PO, Patil DA, Deshmukh PK. 2014. Nanoarchitectonics in cancer therapy and imaging diagnosis. J Nanosci Nanotechnol. 14:828–840.
   PubMed Web of Science ®Google Scholar
• Pandey AP, Sawant KK. 2016. Polyethylenimine: a versatile, multifunctional non-viral vector for nucleic acid delivery. Mater Sci Eng C Mater Biol Appl. 68:904–918.
   PubMed Web of Science ®Google Scholar
• Petersen H, Fechner PM, Martin AL, Kunath K, Stolnik S, Roberts CJ, et al. 2002. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem. 13:845–854.
   PubMed Web of Science ®Google Scholar
• Sang-SooAntonina K, Farwah RR, Abhi KR, Michael CK, Kathleen F, Shangzi PW, et al. 2014. The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells. Mol Therapy. 22:278–291.
   PubMed Web of Science ®Google Scholar
• Tripathi RM, Shrivastav A, Shrivastav BR. 2015. Biogenic gold nanoparticles: as a potential candidate for brain tumor directed drug delivery. Artif Cells Nanomed Biotechnol. 43:311–317.
   PubMed Web of Science ®Google Scholar
• Vader P, Leonardus JA, Schiffelers RM. 2012. Physicochemical and biological evaluation of siRNA polyplexes based on PEGylated poly(amido amine)s. Pharm Res. 29:352–361.
   PubMed Web of Science ®Google Scholar
• Vallier L, Rugg-Gunn PJ, BouhonI A, Andersson FK, Sadler AJ, Pedersen RA. 2004. Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells. 22:2–11.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. 1992. p53 function and dysfunction. Cell. 70:523–526.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mostafa NZ, Hsu CM, Rose L, Kucharki C, Yan J, et al. 2013. Modification of human BMSC with nanoparticles of polymeric biomaterials and plasmid DNA for BMP-2 secretion. J Surg Res. 183:8–17.
   PubMed Web of Science ®Google Scholar
• Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. 2012. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol. 5:173–186.
   PubMed Web of Science ®Google Scholar
• Wightman L, Kircheis R, Roessler V, Carotta S, Ruzicka R, Kursa M, Wagner E. 2001. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med. 3:362–372.
   PubMed Web of Science ®Google Scholar
• Xu G, Wen X, Hong Y, Du H, Zhang X, Song J, et al. 2011. An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human glioma cells. Int Immuno Pharmacol. 11:1844–1849.
   PubMed Web of Science ®Google Scholar
• Xue W, Zender L, Miething C, Dickins RA, Hernando Krizhanovsky E, Lowe SW. 2007. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 445:656–660.
   PubMed Web of Science ®Google Scholar
• Yang F, Moss LG, Phillips GN Jr, 1996. The molecular structure of green fluorescent protein. Nat Biotechnol. 14:1246–1251.
   PubMed Web of Science ®Google Scholar
• Yoshiyuki Tomoko K, Hidetoshi I, Akihiko M, Tatsuya T, Nobuaki O, Haruhiko Y, Takuro AN. 2003. Novel poly(ethylene glycol) derivatives with carboxylic acid pendant groups: synthesis and their protection and enhancing effect on non-viral gene transfection systems. J Biomater Sci Polym Edn. 14:515–531.
   PubMed Web of Science ®Google Scholar
• Zheng M, Zhong Y, Meng F, Peng R, Zhong Z. 2012. Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection. Mol Pharm. 8:2434–2443.
   Google Scholar